Alphatec gets Japanese nod for spine vertebral body replacement devices:
This article was originally published in Clinica
Japanese regulators have given Alphatec Holdings the all-clear to market its NOVEL family of titanium vertebral body replacement devices. The product line addresses the surgical need to accommodate varying patient anatomies and surgical approaches by offering a number of characteristics, says the Carlsbad, California firm. These include "unique" shapes that allow for multiple approaches, each with multiple footprint options; significant area for bone graft; multiple lordotic angles; instrumentation tailored to each implant option; and a patented tooth pattern to prevent device migration and add stability.
You may also be interested in...
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.
The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019.
The Belgian authorities are taking steps to reduce the consumption of benzodiazepine-containing medicines, and have also reiterated the risks associated with the increasing use of opioid medications.